Table I.
Clinical characteristics and association with FGF2 expression.
| FGF2-H group | FGF2-L group | P-value | |
|---|---|---|---|
| Age (n=612) | 0.0043 | ||
| ≥60 | 191 | 224 | |
| <60 | 115 | 82 | |
| Sex (n=612) | 0.1227 | ||
| Female | 111 | 93 | |
| Male | 195 | 213 | |
| TNM stage (n=612) | |||
| I | 25 | 50 | 0.0021 |
| II | 55 | 90 | 0.0009 |
| III | 125 | 102 | 0.4706 |
| IV | 101 | 64 | 0.0008 |
| I+II/III+IV | 80/226 | 140/166 | <0.0001 |
| Lauren (n=612) | |||
| Diffuse | 165 | 90 | <0.0001 |
| Intestinal | 114 | 189 | <0.0001 |
| Mixed | 27 | 27 | 1.0000 |
| T (n=366) | |||
| T1 | 0 | 0 | 1.0000 |
| T2 | 64 | 130 | <0.0001 |
| T3 | 103 | 39 | <0.0001 |
| T4 | 16 | 14 | 0.7031 |
| T1+2/T3+4 | 64/119 | 130/53 | <0.0001 |
| N (n=366) | |||
| N0 | 27 | 24 | 0.6507 |
| N1 | 70 | 86 | 0.0908 |
| N2 | 55 | 50 | 0.5634 |
| N3 | 31 | 23 | 0.2384 |
| N0+1/N2+3 | 97/86 | 110/73 | 0.1704 |
| M (n=366) | 0.1497 | ||
| M0 | 162 | 170 | |
| M1 | 21 | 13 |
FGF2, fibroblast growth factor 2; H, high; L, low.